ANIP SG&A Expense Growth
Ani Pharmaceuticals Inc · SG&A Expense Growth
ANIP SG&A Expense Growth
Latest reported27.28%period ending
ANIP FY SG&A Growth (YoY) (0.00% → 27.28%)
Latest values, visible window
High-resolution chart · PNG
ANIP sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 27.2833% | |
| 54.3851% | |
| 30.3546% | |
| 47.1564% | |
| 29.711% | |
| 16.3727% | |
| 26.7344% | |
| 39.5282% | |
| 13.4787% | |
| 31.5419% | |
| 17.9593% | |
| 9.4398% | |
| 99.1367% | |
| 17.8763% | |
| 17.5264% | |
| 4.7025% | |
| -4.8276% | |
| 37.6324% | |
| -38.3473% | |
| 130.2997% | |
| -0.9603% | |
| 32.3599% | |
| 31.7999% | |
| -23.189% | |
| 36.9406% | |
| 96.6959% | |
| -23.301% | |
| 0% |